DIVIS LABORATORIES
Back to Income Statement
|
DIVIS LABORATORIES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹2,191 Cr | ₹1,600 Cr | ₹1,824 Cr | ₹296,045 Cr | ₹1,984 Cr |
What is the latest Consolidated Net Profit of DIVIS LABORATORIES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹2,191 Cr |
| Mar2025 | ₹1,600 Cr |
| Mar2024 | ₹1,824 Cr |
| Mar2023 | ₹296,045 Cr |
| Mar2022 | ₹1,984 Cr |
How is Consolidated Net Profit of DIVIS LABORATORIES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,191 Cr | 36.94 | |
| Mar2025 | ₹1,600 Cr | -12.28 | |
| Mar2024 | ₹1,824 Cr | -99.38 | |
| Mar2023 | ₹296,045 Cr | 14,819.44 | |
| Mar2022 | ₹1,984 Cr | - | |
Compare Consolidated Net Profit of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹192,701.2 Cr | 4.7% | 9% | 7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,815.0 Cr | 0.5% | 6.2% | 17.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,323.0 Cr | -3.7% | 7.2% | 49.8% | Stock Analytics | |
| CIPLA | ₹114,585.0 Cr | -0.6% | 5% | -3.2% | Stock Analytics | |
| MANKIND PHARMA | ₹102,896.0 Cr | -0.7% | 5.4% | 0.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,067.0 Cr | -1.9% | -4.6% | -2.8% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | 4.7% |
9% |
7% |
| SENSEX | 0.8% |
1.8% |
-6.5% |
You may also like the below Video Courses